Human immunodeficiency virus (HIV) and infertility treatment A committee opinion

Fertility clinics with the necessary resources to provide care should offer services to human immunodeficiency virus (HIV)-infected individuals and couples who are willing to use recommended risk-reducing therapies.

Like Comment

Authors

Ethics Committee of the American Society for Reproductive Medicine

Volume 104, Issue 1, Page e1–e8

Abstract

Human immunodeficiency virus (HIV) is a serious but manageable chronic disease that affects persons of reproductive age, many of whom express a desire for biologic parenthood. This document is a revision of the original document of the same name, last published in 2010 (Fertil Steril 2010;94:11–5).

Read the full text at: http://www.fertstert.org/article/S0015-0282(15)00248-4/fulltext


Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.